Sandoz, a global leader in generic and biosimilar medicines, marked a significant milestone today as it began trading as an independent company on the SIX Swiss Exchange. This momentous occasion follows the successful completion of its spin-off from former parent company Novartis. The opening bell-ringing ceremony at SIX headquarters signalled the start of a new [……
Read More
About The Author
